Open AccessImmunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine
Author(s) -
Jaime Santos,
May Emmeline B. Montellano,
Rontgene Solante,
Nicole Perreras,
Stéphanie Meyer,
Myew–Ling Toh,
Céline Zocchetti,
Claire Vigne,
César Mascareñas
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003220
Subject(s) - dengue vaccine , medicine , tetanus , toxoid , immunogenicity , dengue fever , diphtheria , vaccination , concomitant , plaque reduction neutralization test , titer , immunology , antibody , dengue virus
Incorporating dengue vaccination into existing childhood vaccination programs could increase vaccine coverage. This study assessed the safety and immunogenicity of concomitant versus sequential administration of the combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine and the tetravalent dengue vaccine (CYD-TDV).